Skip to content

Clinical trials

Carcinoma, Transitional Cell trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Transitional Cell Country / region: United States Clear all

350 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20043
20053
20064
20074
20086
20092
20106
20116
20126
20134
20144
201515
201616
201730
201833
201941
202029
202128
202221
202321
202420
202522
202621

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed119
Terminated74
Recruiting73
Active, not recruiting61
Unknown status8
Withdrawn8
Not yet recruiting2
Suspended2
Approved for marketing2
Available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)22
M.D. Anderson Cancer Center14
Memorial Sloan Kettering Cancer Center11
UroGen Pharma Ltd.9
Incyte Corporation8
Pfizer8
Fox Chase Cancer Center7
H. Lee Moffitt Cancer Center and Research Institute7
Bristol-Myers Squibb6
Astellas Pharma Global Development, Inc.5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Transitional Cell350
Urinary Bladder Neoplasms131
Carcinoma, Non-Small-Cell Lung90
Carcinoma, Renal Cell69
Melanoma62
Squamous Cell Carcinoma of Head and Neck54
Colorectal Neoplasms46
Uterine Cervical Neoplasms44
Neoplasm Metastasis42
Ovarian Neoplasms42

Trials

Showing 1 to 25 of 350. Each trial links to its page on Pharma Observatory.

250 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.